What Happens to Aborted Fetuses: From Disposal to Research

In most cases, fetal tissue from an abortion is treated as medical waste and disposed of through regulated processes like incineration or autoclaving (high-pressure steam sterilization). The specific handling depends on the gestational age, the state where the procedure takes place, and whether the patient requests alternative arrangements. In a smaller number of cases, tissue may be sent to a pathology lab for examination or, with explicit written consent, donated to medical research.

Standard Medical Waste Disposal

Fetal tissue from early abortions, particularly in the first trimester, is classified as regulated medical waste in most U.S. states. This puts it in the same category as other surgical tissue, blood products, and biological material removed during medical procedures. Clinics and hospitals are required to follow federal workplace safety rules for handling anything classified as potentially infectious. Staff place tissue in sealed, leak-proof, color-coded containers that are stored securely until a licensed medical waste company picks them up.

The tissue is then destroyed, most commonly through incineration at a specialized facility. Some states also permit autoclaving, which uses pressurized steam to sterilize material before it goes to a sanitary landfill. The exact method varies by jurisdiction and by the waste management company contracted by the clinic or hospital. At no point is fetal tissue simply discarded in regular trash. Every step, from the procedure room to final disposal, follows regulated protocols designed to prevent biohazard exposure.

States That Require Burial or Cremation

A growing number of states have passed laws requiring fetal remains to be buried or cremated rather than processed as medical waste. Indiana is one of at least eight states with such mandates. In 2019, the U.S. Supreme Court upheld Indiana’s law requiring any clinician or facility providing abortion to bury or cremate fetal remains under the same rules that apply to human cadavers.

In these states, clinics typically contract with funeral homes or cremation services to handle the remains. The cost of compliance can be significant, and it falls on the clinic or, in some arrangements, on the patient. Research published in Obstetrics & Gynecology found that private disposition of fetal remains is expensive and not available at all mortuaries, which raises access concerns for families with limited resources. Critics of these laws argue they add financial burden to patients and providers without changing the medical reality of the procedure.

Pathology Examination

In many clinical settings, tissue from a pregnancy (whether ended by abortion or miscarriage) is sent to a pathology lab before disposal. A pathologist examines the tissue both visually and under a microscope. The primary goal is to confirm that the pregnancy was located in the uterus, which rules out a potentially dangerous ectopic pregnancy. The exam can also detect a molar pregnancy, a rare condition where abnormal tissue grows instead of a normal embryo.

During microscopic analysis, a pathologist takes small sections of tissue, embeds them in paraffin wax, slices them into extremely thin layers, stains them, and examines them on glass slides. They look for the presence of specific structures like chorionic villi (tiny finger-like projections from the placenta) to confirm that pregnancy tissue was successfully removed. If less tissue than expected was collected, the pathology results help the clinician determine whether a follow-up procedure is needed. After the examination is complete, the tissue is disposed of through the standard medical waste process.

Donation to Medical Research

Federal law permits fetal tissue to be donated for scientific research, but the process is governed by strict consent rules established under a 1993 statute. The patient must provide written, signed consent specifically for the donation, separate from consent for the abortion itself. Consent for the abortion must be obtained first, before any mention of research donation. The law prohibits altering the timing, method, or procedure of the abortion to accommodate tissue collection.

The attending physician must also disclose any personal financial interest in the research and inform the patient of any medical or privacy risks beyond those of the procedure itself. The patient cannot direct the tissue to a specific recipient or be told who will receive it.

Current NIH policy permits federal funding for research using fetal tissue obtained from miscarriage or stillbirth. Policies on funding research using tissue from elective abortions have shifted across administrations, with various restrictions and reviews imposed over the years. Fetal tissue research has historically contributed to advances in vaccine development, transplantation science, and understanding of diseases like Parkinson’s and HIV.

Fetal Cell Lines and Vaccines

A common source of confusion involves the role of fetal tissue in vaccine production. Some vaccines are manufactured using human cell lines originally derived from two aborted fetuses in the 1960s. These cell lines have been reproducing in laboratories for decades, so no new fetal tissue is needed or used. During vaccine production, purification steps filter out cellular material, and the final vaccines do not contain fetal cells. The American Academy of Pediatrics has confirmed this distinction: the cell lines serve as a biological environment in which to grow viruses, but no fetal tissue ends up in the vaccine itself.

What Patients Can Request

In most states, patients have the option to arrange private burial or cremation of fetal remains after an abortion, regardless of gestational age. This typically involves coordinating with a funeral home or mortuary willing to handle fetal remains. Research surveying mortuaries found that none of those accepting fetal remains had policies excluding tissue from abortion procedures specifically, meaning the service is generally available if a family seeks it.

The practical barrier is cost. Private disposition requires paying for mortuary services, cremation or burial fees, and sometimes transportation. These expenses can be substantial, and not all mortuaries offer the service. For patients who want to arrange private handling, the clinic can usually provide guidance on local options, though availability varies widely by region.